← Back to Dr. Reddy's Laboratories Ltd. overview
Dr. Reddy's Laboratories Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹32,554 cr | ₹5,654 cr | ₹67.79 | ₹49,299 cr | ₹33,339 cr | 16.96% | 20.94% | 0.14x | 17.37% |
| FY2024 | ₹27,916 cr | ₹5,568 cr | ₹66.92 | ₹38,752 cr | ₹28,055 cr | 19.85% | 24.48% | 0.07x | 19.95% |
| FY2023 | ₹24,588 cr | ₹4,507 cr | ₹54.18 | ₹32,185 cr | ₹23,099 cr | 19.51% | 25.28% | 0.06x | 18.33% |
| FY2022 | ₹21,439 cr | ₹2,357 cr | ₹28.34 | ₹29,283 cr | ₹19,053 cr | 12.37% | 14.82% | 0.18x | 10.99% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.